[1] 段薇, 杜建玲, 李昌臣. TSHR与自身免疫性甲状腺疾病关系的研究进展.国外医学内分泌学分册, 2003, 23(1): 40-42.
[2] Tomer Y, Barbesino G, Keddache M, et al. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab, 1997, 82(5): 1645-1648.
[3] Akamizu T, Moriyama K, Miura M, et al. Characterization of recombinant monoclonal antithyrotropin receptor antibodies(TSHRAbs)derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs. Endocrinology, 1999, 140(4): 1594-1601.
[4] Marians RC, Ng L, Blair HC, et al. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA, 2002, 99(24): 15776-15781.  doi: 10.1073/pnas.242322099
[5] García-Jiménez C, Santisteban P. TSH signalling and cancer. Arq Bras Endocrinol Metabol, 2007, 51(5): 654-671.  doi: 10.1590/S0004-27302007000500003
[6] Hoffmann S, Maschuw K, Hassan I, et al. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells. Endocrine, 2006, 30(1): 129-138.
[7] 刘翔, 高明.促甲状腺素抗氧化传导通路与甲状腺乳头状癌侵袭力的关系.中华耳鼻咽喉头颈外科杂志, 2009, 44(4): 287-291.  doi: 10.3760/cma.j.issn.1673-0860.2009.04.006
[8] Rivas M, Santisteban P. TSH-activated signaling pathways in thyroid tumorigenesis. Mol Cell Endocrinol, 2003, 213(1): 31-45.
[9] Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res, 2003, 63(9): 2316-2321.
[10] Yokomori N, Tawata M, Saito T, et al. Regulation of the rat thyrotropin receptor gene by the methylation-sensitive transcription factor GA-binding protein. Mol Endocrinol, 1998, 12(8): 1241-1249.  doi: 10.1210/mend.12.8.0142
[11] Roger PP, van Staveren WC, Coulonval K, et al. Signal transduction in the human thyrocyte and its perversion in thyroid tumors. Mol Cell Endocrinol, 2010, 321(1): 3-19.
[12] Rivas M, Santisteban P. TSH-activated signaling pathways in thyroid tumorigenesis. Mol Cell Endocrinol, 2003, 213(1): 31-45.
[13] Derwahl M, Kuemmel M, Goretzki P, et al. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP. Biochem Biophys Res Commun, 1993, 191(3): 1131-1138.
[14] Shirokawa JM, Elisei R, Knauf JA, et al. Conditional apoptosis induced by oncogenic ras in thyroid cells. Mol Endocrinol, 2000, 14(11): 1725-1738.  doi: 10.1210/mend.14.11.0559
[15] Dumaz N, Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J, 2005, 272(14): 3491-3504.  doi: 10.1111/j.1742-4658.2005.04763.x
[16] De Gregorio G, Coppa A, Cosentino C, et al. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene, 2007, 26(14): 2039-2047.  doi: 10.1038/sj.onc.1210011
[17] Simon D, Körber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging, 2002, 29(6): 775-782.  doi: 10.1007/s00259-001-0737-6
[18] 侯莎莎, 王辉, 冯方, 等.重组质粒hTSHR转染低分化甲状腺癌细胞株后对摄碘能力及特异性基因表达的影响.中华核医学杂志, 2011, 31(2): 92-96.  doi: 10.3760/cma.j.issn.0253-9780.2011.02.005
[19] Paron I, D'Ambrosio C, Scaloni A, et al. A differential proteomic approach to identify proteins associated with thyroid cell transformation. J Mol Endocrinol, 2005, 34(1): 199-207.  doi: 10.1677/jme.1.01618
[20] Kim HJ, Chae HZ, Kim YJ, et al. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol Toxicol, 2003, 19(5): 285-298.  doi: 10.1023/B:CBTO.0000004952.07979.3d
[21] Park JH, Kim YS, Lee HL, et al. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology, 2006, 11(3): 269-275.  doi: 10.1111/j.1440-1843.2006.00849.x